These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

913 related items for PubMed ID: 16302217

  • 21. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
    Wlazłowski M, Celińska W, Maciejka-Kapuścińska L, Płoszyńska A, Idczak E.
    Pol Tyg Lek; ; 49(12-13):296-7. PubMed ID: 7808958
    [Abstract] [Full Text] [Related]

  • 22. Escherichia coli-asparaginase (Elspar) is superior to Erwinia-asparaginase (Erwinase) in childhood acute lymphoblastic leukaemia (ALL) induction--an early response study using minimal residual disease (MRD) markers.
    Kwok CS, Kham SK, Ariffin H, Lin HP, Quah TC, Yeoh AE.
    Ann Acad Med Singap; 2004 Sep; 33(5 Suppl):S45-6. PubMed ID: 15651203
    [No Abstract] [Full Text] [Related]

  • 23. Use of simplified strategies to evaluate early treatment response in childhood acute lymphoblastic leukemia.
    Scrideli CA, de Paula Queiróz R, Bernardes JE, Defavery R, Valera ET, Tone LG.
    Leuk Res; 2006 Aug; 30(8):1049-52. PubMed ID: 16406015
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Clinical importance of minimal residual disease testing in the therapy of childhood B-cell acute lymphoblastic leukemia].
    Ye QD, Gu LJ, Tang JY, Xue HL, Chen J, Pan C, Chen J, Dong L, Zhou M, Jiang LM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):333-6. PubMed ID: 18554462
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Minimal residual disease as a surrogate marker for risk assignment to ALL patients.
    Cazzaniga G, Gaipa G, Rossi V, Biondi A.
    Rev Clin Exp Hematol; 2003 Sep; 7(3):292-323. PubMed ID: 15024971
    [Abstract] [Full Text] [Related]

  • 31. [Minimal residual disease in childhood acute lymphoblastic leukemia: diagnosis of the 21 century].
    Szczepański T, Sońta-Jakimczyk D, Van Dongen JJ.
    Przegl Lek; 2003 Sep; 60 Suppl 5():1-4. PubMed ID: 14574999
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia.
    Björklund E, Mazur J, Söderhäll S, Porwit-MacDonald A.
    Leukemia; 2003 Jan; 17(1):138-48. PubMed ID: 12529671
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease.
    Steinemann D, Cario G, Stanulla M, Karawajew L, Tauscher M, Weigmann A, Göhring G, Ludwig WD, Harbott J, Radlwimmer B, Bartram C, Lichter P, Schrappe M, Schlegelberger B.
    Genes Chromosomes Cancer; 2008 Jun; 47(6):471-80. PubMed ID: 18311775
    [Abstract] [Full Text] [Related]

  • 36. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
    Ruud E, Holmstrøm H, de Lange C, Natvig S, Albertsen BK, Wesenberg F.
    Pediatr Hematol Oncol; 2006 Jun; 23(3):207-16. PubMed ID: 16517537
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement.
    Cheung NK, Chau IY, Coccia PF.
    Am J Pediatr Hematol Oncol; 1986 Jun; 8(2):99-104. PubMed ID: 3526939
    [Abstract] [Full Text] [Related]

  • 40. L-asparaginase related hyperglycemia.
    Iyer RS, Rao SR, Pai S, Advani SH, Magrath IT.
    Indian J Cancer; 1993 Jun; 30(2):72-6. PubMed ID: 8225380
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.